2026 Media Partners

Media Partners

Take a look at the media partners who decided to support the 6th iPSC Drug Development Summit. If you are interested in a media partnership, please contact info@hansonwade.com.

Biopharma Asia

Learn more:

BioPharma Asia aims to keep its readers abreast of all developments in Manufacturing, Development, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters associated with only end-user companies. So, ensuring the information will always be guaranteed to remain timely, informative, and unbiased.

www.biopharma-asia.com

Cell & Gene Therapy Insights

Learn more:

Translation-driven insights across the cell and gene therapy lifecycle

Cell & Gene Therapy Insights is an online, open-access, peer-reviewed journal dedicated to the interdisciplinary exploration and advancement of the field. Through our translational focus, we bridge academia and industry to support preclinical and clinical development, scale-up, and commercialization.

www.insights.bio/cell-and-gene-therapy-insights.com

Gene Therapy Net

Learn more:

Healthcare Business Outlook

Learn more:

At Healthcare Business Outlook Magazine, our mission is simple yet profound: to empower healthcare professionals with the knowledge, insights, and best practices they need to succeed in today’s rapidly changing landscape. We understand that a healthcare facility is not just about providing exceptional patient care—it’s also about navigating complex regulatory environments, optimizing financial performance, and leveraging technology to drive efficiency and innovation.

www.healthcarebusinessoutlook.com

Life Sciences Business Outlook

Learn more:

Life Science Review

Learn more:

Life Science Review Magazine is a print and digital magazine with a total subscription of 124,000 qualified subscribers consisting of senior decision-makers from Pharmaceutical, Biotech, Medical Device and Diagnostic space performing functions in Sales & Marketing, Manufacturing, Supply Chain, R&D, Clinical Operations, Finance, and HR. It provides a comprehensive platform for senior-level industry experts, acquirers, and decision-makers to share their insights following a unique peer learning approach.

www.lifesciencesrevieweurope.com

Media Planet

Learn more:

On September 18, 2026, Mediaplanet will be launching our Cell and Gene Campaign in the Guardian newspaper, online via our Health Awareness site, on socials and at key industry events.

By working in partnership with key industry associations such as MHRA, ISCT, Genomics England, BIA, and many more, this campaign is designed to engage and bring together scientists, biotech partners, investors, clinicians, and the wider public. The campaign seeks to spark conversation around how healthcare systems can evolve from managing disease to delivering equitable access to advanced therapies, including cell and gene therapies that have the potential to transform patients’ conditions.

If you are interested in joining this edition or discussing any of our other campaigns, please reach out to amy.shah@mediaplanet.com

Pharma Business Outlook

Learn more:

Pharma Business Outlook is more than just a publication, it is a bridge that connects pharmaceutical companies, healthcare providers, and key decision-makers. By fostering discussions on regulatory compliance, emerging market opportunities, and digital transformation, the magazine plays a crucial role in shaping the future of the pharmaceutical ecosystem. Whether exploring the latest innovations in clinical trials or uncovering strategies to enhance patient outcomes, Pharma Business Outlook remains a trusted resource for professionals committed to advancing the industry.

www.pharmabusinessoutlook.com

Pharma Focus America

Learn more:

Pharma Focus America, a premier B2B global digital publication, is a vital resource for pharmaceutical professionals navigating the dynamic landscape of the Americas. Offering real-time insights and comprehensive coverage, our platform is a beacon for industry leaders, providing a nuanced perspective on trends, innovations, and regulatory shifts. With a commitment to excellence, we deliver thought-provoking analyses, exclusive interviews, and breaking news, empowering our audience to make informed decisions. Pharma Focus America is your gateway to staying abreast of the latest developments in pharmaceuticals, fostering a community that thrives on knowledge and collaboration in the rapidly evolving world of healthcare.

www.pharmafocusamerica.com

RegMedNet

Learn more:

RegMedNet aims to educate and inspire the regenerative medicine and cell and gene therapy community to accelerate innovation and expand treatment options for patients. In partnership with the peer-reviewed journal Regenerative Medicine and the Taylor & Francis portfolio, RegMedNet delivers comprehensive coverage of the entire cell, gene and regenerative therapies landscape from discovery to delivery, covering:

Preclinical research: stem cell biology, tissue regeneration mechanisms and the biological principles underlying cell and gene therapies
Therapeutic development: cell therapies, gene therapies, tissue engineering, organ replacement strategies and regenerative pharmacology approaches
Manufacturing: bioprocessing, scale-up, quality control and cost of goods specifically for cell, gene and regenerative therapy production
Regulatory pathways: clinical trials, approval processes, policy frameworks and reimbursement models for advanced regenerative therapies
Industry and commercialization: business strategies, market developments, investment trends and government policy shaping the cell, gene and regenerative therapies sector
Broader context: ethical considerations, legal frameworks and societal implications of cell, gene and regenerative medicine

On RegMedNet, you can find free educational webinars, expert opinion and insight articles and exclusive peer-reviewed journal articles, as well as the latest news and advances. By integrating timely industry insights with access to peer-reviewed research, RegMedNet serves as an essential knowledge hub for researchers, manufacturers, clinicians, regulators and commercial stakeholders advancing the field.

www.regmednet.com

STEMCELL Science News

Learn more:

Networking at the 6th iPSC Drug Development Summit

Explore the 2026 Agenda

See where the bottlenecks really are and how teams are solving them.

This agenda goes beyond theory to highlight the decisions shaping real iPSC programs, from line selection and genome integrity to late stage scale up, comparability, and regulatory confidence.

View 2026 Presentations & Speakers

Partner With Us

Shape the discussion at the point where priorities are being set.

Partnering with the summit gives you a unique opportunity to position your organization at the heart of the iPSC community, build meaningful connections, and become the go-to partner for the iPSC community.

Explore Sponsorship Options

Audience at the 6th iPSC Drug Development Summit

Join the iPSC Community

Connect with a field that has moved past experimentation.

Meet a focused community of leaders working through the realities of clinical translation, manufacturing scale, and regulatory alignment. Biopharma and academics can attend for free!

2026 Media Partners

Media Partners

Biopharma Asia

Cell & Gene Therapy Insights

Gene Therapy Net

Healthcare Business Outlook

Life Sciences Business Outlook

Life Science Review

Media Planet

Pharma Business Outlook

Pharma Focus America

RegMedNet

STEMCELL Science News

Explore the 2026 Agenda

Partner With Us

Join the iPSC Community

Contact

Join Our Team

About Us

Explore Our Conferences

Stay Connected

Search

Organized By